Login / Signup

Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.

Praful RaviGregory R PondLeonidas N DiamantopoulosChristopher SuAjjai AlvaRohit K JainWilliam Paul SkeltonSumati GuptaJonathan D TwardKathleen M OlsonParminder SinghCamilla M GrunewaldGuenter NiegischJae-Lyun LeeAndrea GallinaMarco BandiniAndrea NecchiMatthew MossanenBradley A McGregorCatherine CurranPetros GrivasGuru P Sonpavde
Published in: BJU international (2021)
We propose that optimal pathological response after NAC be defined as attainment of ypT0N0/ypTisN0 at RC. Patients with ypTaN0 or ypT1N0 disease (with or without Tis) at RC displayed a significantly higher risk of recurrence and may be candidates for trials investigating adjuvant therapy.
Keyphrases
  • neoadjuvant chemotherapy
  • muscle invasive bladder cancer
  • locally advanced
  • lymph node
  • sentinel lymph node
  • clinical trial
  • transcription factor
  • study protocol
  • radiation therapy
  • rectal cancer
  • early stage